Ruth, here. Perhaps the most interesting news of the week is from Updoc, a clinical platform that combines traditional physician-led medicine with AI to deliver primary care. This week, the Food and Drug Administration authorized the company to use AI to tweak insulin doses for patients with Type 2 diabetes. Cleveland Clinic will be running a pilot of the program in the fall, wherein Updoc’s bot does patient follow-up, reviews their glucose levels, and adjusts medication as needed.